HUTCHMED (China) (HCM) Depreciation & Amortization (CF) (2018 - 2019)
HUTCHMED (China) (HCM) posted quarterly Depreciation & Amortization (CF) of $1.3 million for Q4 2019, up 27.24% year-over-year from $1.0 million in Q4 2018, and up 6.43% quarter-over-quarter from $1.2 million in Q3 2019.
HUTCHMED (China) (HCM) Depreciation & Amortization (CF) (2018 - 2019) Analysis & Trends
HUTCHMED (China) (HCM) has reported Depreciation & Amortization (CF) for 2 consecutive years, with $1.3 million the latest figure, recorded in Q4 2019.
- In Q4 2019, Depreciation & Amortization (CF) rose 27.24% year-over-year to $1.3 million; the TTM figure through Dec 2020 stood at $1.3 million (down 48.44% YoY), while the FY2025 annual figure was $13.3 million, up 7.84% from the prior year.
- Depreciation & Amortization (CF) improved to $1.3 million in Q4 2019 per HCM's latest filing, from $1.2 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.3 million in Q4 2019 and bottomed at $874000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | HUTCHMED (China) | 2.17 Bn | 2.17 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 1.31 Mn |
| Dec 31, 2019 | 1.31 Mn |
| Sep 30, 2019 | 1.23 Mn |
| Sep 30, 2019 | 1.23 Mn |
| Dec 31, 2018 | 1.03 Mn |
| Dec 31, 2018 | 1.03 Mn |
| Sep 30, 2018 | 874,000.00 |
| Sep 30, 2018 | 874,000.00 |